OJO  Vol.2 No.3 , September 2012
Pediatric Primary Malignant Lymphoma of the Spine: A Case Report
Abstract: Background: Cases of primary malignant lymphomas of the bone are rare and account for about <1% of all lymphomas and 5% of extranodal non-Hodgkin’s lymphomas. Furthermore, most reports have described the occurrence of this disease in the middle-aged population, pediatric malignant lymphomas originating in the bone, particularly in the spine is rare. Methods: A 10-year-old boy presented with low back pain caused by T12 vertebral compression fracture due to sustaining a fall. A month later, he still presented with prolonged low back pain that intensified after exercise. A neoplastic lesion in T12 vertebral body was identified after spine computed tomography (CT) and magnetic resonance imaging. Results: We performed CT-guided biopsy, and he was diagnosed with primary malignant lymphoma of the vertebral body. He was treated with multiagent chemotherapy without irradiation, and complete remission was maintained at the 5-year follow-up. Moreover, the height of the deformed vertebral body improved as he grew. Conclusions: Herein, we report a rare case of pediatric primary malignant lymphoma of the spine with successful clinical and radiological outcome.
Cite this paper: D. Kudo, N. Miyakoshi, M. Hongo, Y. Kasukawa, Y. Ishikawa, H. Aonuma and Y. Shimada, "Pediatric Primary Malignant Lymphoma of the Spine: A Case Report," Open Journal of Orthopedics, Vol. 2 No. 3, 2012, pp. 85-89. doi: 10.4236/ojo.2012.23017.

[1]   Eeles RA, O'Brien P, Horwich A and Brada M, “Non-Hodgkin's lymphoma presenting with extradural spinal cord compression: functional outcome and survival,” British journal of cancer, Vol. 63, No. 1, 1991, pp. 126-129.

[2]   Sandlund JT, Downing JR and Crist WM, “Non-Hodgkin's lymphoma in childhood,” The New England journal of medicine, Vol. 334, No. 19, 1996, pp. 1238-1248.

[3]   Fairbanks RK, Bonner JA, Inwards CY, Strickler JG, Habermann TM, Unni KK and Su J, “Treatment of stage IE primary lymphoma of bone,” International journal of radiation oncology, biology, physics, Vol. 28, No. 2, 1994, pp. 363-372.

[4]   [4] Freeman C, Berg JW and Cutler SJ, “Occurrence and prognosis of extranodal lymphomas,” Cancer, Vol. 29, No. 1, 1972, pp. 252-260.

[5]   [5] Barbieri E, Cammelli S, Mauro F, Perini F, Cazzola A, Neri S, Bunkheila F, Ferrari S, Brandoli V, Zinzani P, Mercuri M and Bacci G, “Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for Stage I and Stage II,” International journal of radiation oncology, biology, physics, Vol. 59, No. 3, 2004, pp. 760-764.

[6]   [6] Rathmell AJ, Gospodaro-wicz MK, Sutcliffe SB and Clark RM, “Localised lymphoma of bone: prognostic factors and treatment recommendations. The Princess Margaret Hospital Lymphoma Group,” British journal of cancer, Vol. 66, No. 3, 1992, pp. 603-606.

[7]   [7] Zinzani PL, Carrillo G, Ascani S, Barbieri E, Tani M, Paulli M, Stefoni V, Sabattini E, Alinari L, Binazzi R, Tura S, Baccarani M and Pileri SA, “Primary bone lymphoma: experience with 52 patients,” Haematologica, Vol. 88, No. 3, 2003, pp. 280-285.

[8]   [8] Glotzbecker MP, Kersun LS, Choi JK, Wills BP, Schaffer AA and Dormans JP, “Primary Non-Hodgkin's Lymphoma of Bone in Children,” The Journal of bone and joint surgery. American volume, Vol. 88, No. 3, 2006, pp. 583-594.

[9]   Limb D, Dreghorn C, Murphy JK and Mannion R, “Primary lymphoma of bone,” International orthopaedics, Vol. 18, No. 3, 1994, pp. 180-183.

[10]   Ching HY, Horsman JM, Radstone CR, Hancock H, Timperley WR and Hancock BW, “Non-Hodgkin's lymphoma presenting with spinal involvement: the Sheffield Lymphoma Group experience (1970-2000),” International journal of oncology, Vol. 19, No. 1, 2001, pp. 149-156.

[11]   Moulopoulos LA and Dimopoulos MA, “Magnetic resonance imaging of the bone marrow in hematologic malignancies,” Blood, Vol. 90, No.6, 1997, pp. 2127-2147.

[12]   Murphy SB, “Childhood non-Hodgkin’s lymphoma,” The New England journal of medicine, Vol.299, No. 26, 1978, pp. 1446-1448.

[13]   Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, Lutz P, Coze C, Perel Y, Raphael M, Terrier-Lacombe MJ and Société Francaise d'Oncologie Pédiatrique, “The Société Francaise d'Oncologie Pédia-trique LMB89 protocol: highly effective multiagent chemothe-rapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia,” Blood, Vol. 97, No. 11, 2001, pp. 3370-3379.

[14]   Nakano M, Hirano N, Ishihara H, Kawaguchi Y, Watanabe H and Matsuura K, “Calcium phosphate cement-based vertebroplasty compared with conservative treatment for osteoporotic compression fractures: a matched case-control study,” Journal of neurosurgery. Spine, Vol. 4. No. 2, 2006, pp. 110-117.

[15]   Vaughan JJ, Winter RB, Lonstein JE, Johnson JR and Dunnington JE, “Non-Hodgkin lymphoma of the spine: a report of three cases with a minimum ten-year follow-up,” The Journal of bone and joint surgery. American volume, Vol. 80. No. 1, 1998, pp. 104-110.

[16]   Kim HJ, Ryu KN, Choi WS, Choi BK, Choi JM and Yoon Y, “Spinal involvement of hematopoietic malignancies and metastasis: differentiation using MR imaging,” Clinical imaging, Vol. 23, No. 2, 1999, pp. 125-133.

[17]   Haussler MD, Fenstermacher MJ, Johnston DA and Harle TS, “MRI of primary lymphoma of bone: cortical disorder as a criterion for differential diagnosis,” Journal of magnetic resonance imaging, Vol. 9, No. 1, 1999, pp. 93-100.

[18]   Linden A, Zankovich R, Theissen P, Diehl V and Schicha H, “Malignant lymphoma: bone marrow imaging versus biopsy,” Radiology, Vol.173, No. 2, 1989, pp. 335-339.

[19]   Moulopoulos LA, Dimopoulos MA, Vourtsi A, Gouliamos A and Vlahos L, “Bone lesions with soft-tissue mass: magnetic resonance imaging diagnosis of lymphomatous involvement of the bone marrow versus multiple myeloma and bone metastases,” Leukemia & lymphoma, Vol. 34. No. 1-2, 1999, pp. 179-184.

[20]   Puri A, Shingade VU, Agarwal MG, Anchan C, Juvekar S, Desai S and Jambhekar NA, “CT-guided percutaneous core needle biopsy in deep seated musculoskeletal lesions: a prospective study of 128 cases,” Skeletal radiology, Vol. 35, No. 3, 2006, pp. 138-143.

[21]   Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M, Mann G, Chott A, Ebell W, Klin-gebiel T, Graf N, Kremens B, Müller-Weihrich S, Plüss HJ, Zintl F, Henze G and Riehm H, “Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90,” Blood, Vol. 94, No. 10, 1999, pp. 3294-3306.

[22]   Tsurusawa M, Taga T, Horikoshi Y, Ogawa A, Kikuta A, Kanegane H, Matsushita T, Hyakuna N, Shimomura Y, Ohshima K and Lymphoma Committee of Japanese Childhood Cancer and Leukemia, “Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: a report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group,” Leukemia & lymphoma, Vol. 49, No. 4, 2008, pp. 734-739.

[23]   Bluhm EC, Ronckers C, Hayashi RJ, Neglia JP, Mertens AC, Stovall M, Meadows AT, Mitby PA, Whitton JA, Hammond S, Barker JD, Donaldson SS, Robison LL and Inskip PD, “Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study,” Blood, Vol. 111, No. 8, 2008, pp. 4014-4021.

[24]   Lones MA, Perkins SL, Sposto R, Tedeschi N, Kadin ME, Kjeldsberg CR, Wilson JF, Zwick DL and Cairo MS, “Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report,” Journal of clinical oncology, Vol. 20, No. 9, 2002, pp. 2293-2301.

[25]   Raab P, Hohmann F, Kühl J and Krauspe R, “Vertebral remodeling in eosinophilic granuloma of the spine. A long-term follow-up,” Spine, Vol. 23, No. 12, 1998, pp. 1351-1354.